Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial

Recruiting now · Not applicable

Conditions studied: Knee Osteoarthritis

In brief

Cooled radiofrequency ablation (cRFA) of the knee geniculate nerves is a promising treatment option for knee osteoarthritis, but has variable efficacy. Fluoroscopy is the typical guidance of choice, but uses bony landmarks to target these nerves which have variable positions around the knee. Alternatively, ultrasound allows for targeting based on visualization of bony landmarks, the nerves, and their accompanying vascular structures, and thus may offer greater accuracy. However, there are few studies which directly compare the clinical efficacy of these two guidance options. This study will compare these two options.

Key facts

Study ID

NCT04472702

Run by

University of California, Davis

People needed

90

Starts

2022-02-02

Expected to finish

2027-05-01

Last updated by the study team

2026-06-16

Who can join

Age: 35 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1) patients of either gender with primary knee OA of one or both knees fulfilling the diagnostic criteria for knee OA by the American College of Rheumatology,
• 2) Kellgren-Lawrence score of two to four,
• 3) reported NPRS pain intensity of at least four on most or all days of the past week
• 4) pain resistant to conventional treatments which may include but is not limited to medications (e.g. acetaminophen, oral or topical non-steroidal anti-inflammatory drugs, opioids), physical therapy, and intra-articular injections (e.g. corticosteroids, hyaluronic acid, platelet-rich-plasma) for at least 3 months. In the case of bilateral knee OA, the most symptomatic knee will be treated and studied.

You may not qualify if…

• 1) age <35 years,
• 2) non-English speaking patients,
• 3) body mass index greater than 40,
• 4) previous radiofrequency ablation procedure for the knee,
• 5) active systemic or local infections at the site of needle/cRFA probe placement,
• 6) previous knee joint replacement surgery,
• 7) autoimmune or inflammatory cause of knee arthritis such as rheumatoid or psoriatic arthritis,
• 8) non-ambulatory patients,
• 9) patients who are unable to provide their own consent (e.g. dementia),
• 10) unstable medical or psychiatric illness,
• 11) patients with pacemakers, spinal cord stimulators, deep brain stimulators, or similar devices,
• 12) patients seeking care as a part of workman's compensation or have litigation pending
• 13) a negative response to diagnostic geniculate nerve lidocaine injections.

Where it is running

• University of Rochester — Rochester, New York, United States (enrolling)
• UC Davis Health — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.